IARPA PICARD Program Proposers’ Day
The IARPA Pursuing Intelligent Complex Aerosols for Rapid Detection (PICARD) program will host a Proposer's Day on 26 September 2022 to introduce the PICARD program to potential proposers and to
The IARPA Pursuing Intelligent Complex Aerosols for Rapid Detection (PICARD) program will host a Proposer's Day on 26 September 2022 to introduce the PICARD program to potential proposers and to
The goal of the Global Bioequivalence Harmonization Initiative (GBHI) conference is to offer the most informative and up to date science and regulation of bioequivalence in global drug development. The
The next public meeting of the National Biodefense Science Board (NBSB) will take place on Thursday, September 29. Join NBSB members, distinguished guests, federal leaders, and subject matter experts exploring
FDA's Center for Biologics Evaluation and Research (CBER) will host a free virtual format workshop on 5 October 2022 entitled Study Data Standards Update for CBER: Your Guide to a
The FDA Vaccines and Related Biological Products Advisory Committee will convene on 6 October 2022 in open session to discuss the Strain Selection for the Influenza Virus Vaccines for the
The FDA NanoDay Symposium 2022 will be held on 11 October 2022. The event will address drug development of products that contain nanomaterials in their formulation and how the newly
The multi-attribute method (MAM) is a liquid chromatography-mass spectrometry (LC-MS) based peptide mapping approach used for the identification and quantitation of product quality attributes (PQAs) in therapeutic proteins. The U.S.
The CDC has announced the Board of Scientific Counselors, National Center for Health Statistics (BSC, NCHS) will convene 24 October 2022 in a live broadcast public meeting. The Board is
The FDA will host a meeting on 26 October 2022 to provide additional clarity to the final guidance with respect to Agency expectations for submissions containing Bioavailability information for drug